NANOFX PLEURISTIK
Report
- Report Number
- 3004154314-2017-00025
- Event Type
- Malfunction
- Date Received
- December 13, 2017
- Date of Event
- November 14, 2017
- Report Date
- November 14, 2017
- Manufacturer
- ARTHROSURFACE, INC.
- Product Code
- LXH
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MA, US
- Reporter Occupation
- MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE
Narratives
THE EXACT CAUSE FOR BREAKING OF THE NANOFX NEEDLE IS UNKNOWN. ACCORDING TO THE REP WHO ATTENDED THE CASE, THE SURGEON IS FAMILIAR WITH THE PROCEDURE AND HAS PERFORMED SEVERAL NANOFX CASES PREVIOUSLY. THE BROKEN PARTS WERE DISCARDED BY THE FACILITY. HENCE INVESTIGATION OF THE ROOT CAUSE IS NOT POSSIBLE. A REVIEW OF PREVIOUSLY LOGGED COMPLAINTS WAS PERFORMED AND NOTED THAT THIS IS THE FIRST COMPLAINT FROM THE SUSPECT LOT (LOT SIZE - 560 UNITS). ALSO, THE DHR REVIEW OF THE SUSPECT LOT WAS REVIEWED. NO NON-CONFORMITIES OR REJECTS WERE FOUND RELEVANT TO THE ISSUE. ALL TEST RESULTS (MATERIAL ANALYSIS, TENSILE STRENGTH, 100% GAUGE INSPECTION ETC.,) WITHIN THE SPECIFICATIONS AND ALL APPLICABLE STANDARDS. THIS LOT WAS MANUFACTURED IN 2015 AND SINCE HAS BEEN IN THE FIELD WITHOUT ISSUES. FINDINGS FROM PREVIOUS COMPLAINTS INDICATE QUALITY OF BONE, USE OF EXCESSIVE FORCE, WEAR ON THE GUIDE HANDLE, LACK OF THUMB TAB TO RETRACT THE NEEDLE ETC, MAY IMPACT THE FUNCTIONALITY OF THE NANOFRACTURE DEVICE. ALL BROKEN PIECES WERE RETRIEVED FROM THE PATIENT'S BONE. THERE WAS NO HARM OR INJURY TO THE USER OR TO THE PATIENT AS A RESULT OF THE REPORTED ISSUE. THE SURGEON FINISHED THE CASE USING A SECOND NANOFX NEEDLE READILY AVAILABLE WITH THE REP. WE WILL CONTINUE TO TRACK AND TREND.
A NANOFX NEEDLE WAS BROKEN WHILE PERFORMING MICROFRACTURE TECHNIQUE. THE NEEDLE BROKE INTO 3 PIECES FOLLOWING THE IMPACTION.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 891833 | NANOFX PLEURISTIK | ORTHOPEDIC MANUAL SURGICAL INSTRUMENT | LXH | ARTHROSURFACE, INC. | 75AE1904 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Other |